Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Publisher： Karger

E-ISSN： 2235-3186|133|3|147-158

ISSN： 1660-8151

Source： Nephron, Vol.133, Iss.3, 2016-06, pp. : 147-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria

By  

Kidney and Blood Pressure Research, Vol. 39, Iss. 6, 2014-12 ,pp. : 573-580

Karger

Access to resources Recommend Favorite

Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Contrast-Induced Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 38, Iss. 2-3, 2014-03 ,pp. : 165-171

Karger

Access to resources Recommend Favorite

Renoprotective Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Diabetic Patients with Proteinuria

By  

Kidney and Blood Pressure Research, Vol. 42, Iss. 2, 2017-06 ,pp. : 358-368

Karger

Access to resources Recommend Favorite

Diuretics versus Angiotensin-Converting Enzyme Inhibitors in Autosomal Dominant Polycystic Kidney Disease

By  

American Journal of Nephrology, Vol. 21, Iss. 2, 2001-05 ,pp. : 98-103

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal Disease

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 106-108

Karger

Access to resources Recommend Favorite